Meta-Analysis of Adverse Cardiovascular Outcomes Associated With Antecedent Hypertension After Myocardial Infarction

American Journal of Cardiology

Volumn 104, Issue 1, 2009, Pages 141-147

  Chen, Guanmin ^a   Hemmelgarn, Brenda ^a,b   Alhaider, Sami ^a   Quan, Hude ^a   Campbell, Norm ^a,b   Rabi, Doreen ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONOLOGY; CONGESTIVE HEART FAILURE; DEATH; DISEASE ASSOCIATION; EMBASE; HEART DEATH; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; INTERNAL BIAS; MEDLINE; MORTALITY; PRIORITY JOURNAL; PUBLICATION; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; STROKE; SYSTEMATIC REVIEW;

AGED; CARDIOVASCULAR DISEASES; CONFIDENCE INTERVALS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; RISK; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 67649378614     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.02.048     Document Type: Review

References (29)

1. Egger M., Davey S.G., and Atltman D. Systematic Reviews in Health Care. Meta-Analysis in Context (2001), BMI, London, UK 122-142
2. Moher D., Cook D.J., Eastwood S., Olkin I., Rennie D., and Stroup D.F. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 354 (1999) 1896-1900
3. Jaffe A.S., Krumholz H.M., Catellier D.J., Freedland K.E., Bittner V., Blumenthal J.A., Calvin J.E., Norman J., Sequeira R., O'Connor C., Rich M.W., Sheps D., and Wu C. Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Trial Investigators. Prediction of medical morbidity and mortality after acute myocardial infarction in patients at increased psychosocial risk in the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) study. Am Heart J 152 (2006) 126-135
4. Henning R., and Wedel H. The long-term prognosis after myocardial infarction: a five year follow-up study. Eur Heart J 2 (1981) 65-74
5. Kitchin A.H., and Pocock S.J. Prognosis of patients with acute myocardial infarction admitted to a coronary care unit. II. Survival after hospital discharge. Br Heart J 39 (1977) 1167-1171
6. Herlitz J., Karlson B.W., Richter A., Wiklund O., Jablonskiene D., and Hjalmarson A. Prognosis in hypertensives with acute myocardial infarction. J Hypertens 10 (1992) 1265-1271
7. Tofler G.H., Muller J.E., Stone P.H., Willich S.N., Davis V.G., Poole W.K., and Braunwald E. Factors leading to shorter survival after acute myocardial infarction in patients ages 65-75 years compared with younger patients. Am J Cardiol 62 (1988) 860-867
8. von Elm E., Altman D.G., Egger M., Pocock S.J., Gotzsche P.C., and Vandenbroucke J.P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370 (2007) 1453-1457
9. Zhang J., and Yu K.F. What's the relative risk?. A method of correcting the odds ratio in cohort studies of common outcomes. J Am Med Assoc 280 (1998) 1690-1691
10. Kenchaiah S., Davis B.R., Braunwald E., Rouleau J.-L., Dagenais G.R., Sussex B., Steingart R.M., Brown E.J., Lamas G.A., Gordon D., Bernstein V., and Pfeffer M.A. Survival and Ventricular Enlargement Trial. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: insights from the Survival and Ventricular Enlargement Trial. Am Heart J 148 (2004) 356-364
11. Lewis E.F., Moye L.A., Rouleau J.L., Sacks F.M., Arnold J.M., Warnica J.W., Flaker G.C., Braunwald E., and Pfeffer M.A. Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study. J Am Coll Cardiol 42 (2003) 1446-1453
12. Hellermann J.P., Jacobsen S.J., Redfield M.M., Reeder G.S., Weston S.A., and Roger V.L. Heart failure after myocardial infarction: clinical presentation and survival. Eur J Heart Fail 7 (2005) 119-125
13. Hellermann J.P., Goraya T.Y., Jacobsen S.J., Weston S.A., Reeder G.S., Gersh B.J., Redfield M.M., Rodeheffer R.J., Yawn B.P., and Roger V.L. Incidence of heart failure after myocardial infarction: is it changing over time?. Am J Epidemiol 157 (2003) 1101-1107
14. Haider A.W., Chen L., Larson M.G., Evans J.C., Chen M.H., and Levy D. Antecedent hypertension confers increased risk for adverse outcomes after initial myocardial infarction. Hypertension 30 (1997) 1020-1024
15. Martin C.A., Thompson P.L., Armstrong B.K., Hobbs M.S., and de Klerk N. Long-term prognosis after recovery from myocardial infarction: a nine year follow-up of the Perth Coronary Register. Circulation 68 (1983) 961-969
16. Gustafsson F., Kober L., Torp-Pedersen C., Hildebrandt P., Ottesen M.M., Sonne B., Carlsen J., and TRACE Study Group. Long-term prognosis after acute myocardial infarction in patients with a history of arterial hypertension. Eur Heart J 19 (1998) 588-594
17. Kenchaiah S., Pfeffer M.A., St. John Sutton M., Plappert T., Rouleau J.L., Lamas G.A., Sasson Z., Parker J.O., Geltman E.M., and Solomon S.D. Effect of antecedent systemic hypertension on subsequent left ventricular dilation after acute myocardial infarction (from the Survival and Ventricular Enlargement trial). Am J Cardiol 94 (2004) 1-8
18. Thune J.J., Signorovitch J., Kober L., Velazquez E.J., McMurray J.J., Califf R.M., Maggioni A.P., Rouleau J.L., Howlett J., Zelenkofske S., et al. Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction. Hypertension 51 (2008) 48-54
19. Fresco C., Avanzini F., Bosi S., Franzosi M.G., Maggioni A.P., Santoro L., Bellanti G., and GISSI-2 Investigators. Prognostic value of a history of hypertension in 11,483 patients with acute myocardial infarction treated with thrombolysis. J Hypertens 14 (1996) 743-750
20. Kornowski R., Goldbourt U., Zion M., Mandelzweig L., Kaplinsky E., Levo Y., Behar S., and SPRINT Study Group. Predictors and long-term prognostic significance of recurrent infarction in the year after a first myocardial infarction. Am J Cardiol 72 (1993) 883-888
21. Witt B.J., Brown Jr. R.D., Jacobsen S.J., Weston S.A., Yawn B.P., and Roger V.L. A community-based study of stroke incidence after myocardial infarction. Ann Intern Med 143 (2005) 785-792
22. Richards A.M., Nicholls M.G., Troughton R.W., Lainchbury J.G., Elliott J., Frampton C., Espiner E.A., Crozier I.G., Yandle T.G., and Turner J. Antecedent hypertension and heart failure after myocardial infarction. J Am Coll Cardiol 39 (2002) 1182-1188
23. Sans S., Kesteloot H., and Kromhout D. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. The burden of cardiovascular diseases mortality in Europe. Eur Heart J 18 (1997) 1231-1248
24. Goraya T.Y., Jacobsen S.J., Kottke T.E., Frye R.L., Weston S.A., and Roger V.L. Coronary heart disease death and sudden cardiac death: a 20-year population-based study. Am J Epidemiol 157 (2003) 763-770
25. Smith J.S.C., Allen J., Blair S.N., Bonow R.O., Brass L.M., Fonarow G.C., Grundy S.M., Hiratzka L., Jones D., Krumholz H.M., Mosca L., Pasternak R.C., Pearson T., Pfeffer M.A., and Taubert K.A. Guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol 47 (2006) 2130-2139
26. Rosendorff C., Black H.R., Cannon C.P., Gersh B.J., Gore J., Izzo Jr. J.L., Kaplan N.M., O'Connor C.M., O'Gara P.T., and Oparil S. REPRINT treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Hypertension 50 (2007) e28-e55
27. Thompson S.G. Why sources of heterogeneity in meta-analysis should be investigated. BMJ 309 (1994) 1351-1355
28. Faddy S.C. Significant statistical heterogeneity in a meta-analysis of the usefulness of acetylcysteine for prevention of contrast nephropathy. Am J Cardiol 94 (2004) 414
29. Unal B., Critchley J.A., and Capewell S. Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention. BMJ 331 (2005) 614